References

Enarson D. Fostering a spirit of critical thinking: the ISAAC story. Int J Tuberc Lung Dis 2005;9:1.

Pawankar R, Baena-Cagnani CE, Bousquet J, et al. State of World Allergy Report 2008: Allergy and Chronic Respiratory Diseases. World Allergy Organisation Journal. 2008(Supplement 1):s4-s17.

World Health Organisation. Global Alliance against chronic respiratory diseases (GARD) basket: a package of information, surveillance tools and guidelines, to be offered as a service to countries. Geneva: World Health Organisation; 2008

Aït-Khaled N, Pearce N, Anderson HR, Ellwood P, Montefort S, Shah J, and the ISAAC Phase Three Study Group. Global map of the prevalence of symptoms of rhinoconjunctivitis in children: The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three. Allergy 2009; 64: 123–148.

Anderson HR, Gupta R, Kapetanakis V, Asher MI, Clayton T, Robertson CF, Strachan DP, and the ISAAC Steering Committee. International correlations between indicators of prevalence, hospital admissions and mortality for asthma in children. Int J Epidemiol 2008; 37(3):573-82.

Anderson HR, Poloniecki JD, Strachan DP, Beasley R, Björkstén B, Asher MI, and the ISAAC Phase One Study Group. Immunization and symptoms of atopic disease in children: Results from the International Study of Asthma and Allergies in Childhood. Am J Publ Health 2001; 91(7): 1126-9.

Anderson HR, Ruggles R, Pandey KD, Kapetenakis V, Brunekreef B, Lai CKW, Strachan DP, Weiland SK, and the ISAAC Phase One Study Group. Ambient particulate pollution and the world-wide prevalence of asthma, rhinoconjunctivitis and eczema in children: Phase One of the International Study of Asthma and Allergies in Childhood (ISAAC). Occup Environ Med 2010; 67(5): 293-300. doi:10.1136/oem.2009.048785. epub: 9 October 2009.

Asher MI, Montefort S, Björkstén B, Lai CKW, Strachan DP, Weiland SK, Williams H, and the ISAAC Phase Three Study Group. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006; 368(9537): 733-743.

Asher MI, Stewart AW, Mallol J, Montefort M, Lai CKW, Aït-Khaled N, Odhiambo J, and the ISAAC Phase One Study Group. Which population level environmental factors are associated with asthma, rhinoconjunctivitis and eczema? A review of the ecological analyses of ISAAC Phase One. Respiratory Research. 2010; 11(8):

Beasley R, Clayton T, Crane J, von Mutius E, Lai CKW, Montefort S, Stewart A, for the ISAAC Phase Three Study Group. Association between paracetamol use in infancy and childhood, and risk of asthma, rhinoconjunctivitis, and eczema in children aged 6-7 years: analysis from Phase Three of the ISAAC programme. Lancet 2008; 372(9643): 1039-48.

Beasley RW, Clayton TO, Crane J, Lai CKW, Montefort SR, von Mutius E, Stewart AW, and the ISAAC Phase Three Study Group. Acetaminophen Use and Risk of Asthma, Rhinoconjunctivitis and Eczema in Adolescents: ISAAC Phase Three Am J Resp Crit Care Med. 2011; 183(2): 171-178.

Björkstén B, Clayton T, Ellwood P, Stewart A, Strachan D, and the ISAAC Phase Three Study Group. Worldwide time trends for symptoms of rhinitis and conjunctivitis: Phase III of the International Study of Asthma and Allergies in Childhood. Pediatr Allergy Immunol 2008; 19(2): 110-24.

Brunekreef B, Stewart AW, Anderson HR, Lai CKW, Pearce NE, and the Phase Three Study Group. Self Reported Truck Traffic on the Street of Residence and Symptoms of Asthma and Allergic Disease: A Global Relationship in ISAAC Phase Three. Environ Health Perspect 2009; 117(11): 1791-98. Epub July 2009.

Burr ML, Emberlin JC, Treu R, Cheng S, Pearce NE, and the ISAAC Phase One Study Group. Pollen counts in relation to the prevalence of allergic rhinoconjunctivitis, asthma and atopic eczema in the International Study of Asthma and Allergies in Childhood (ISAAC). Clin Exp Allergy 2003; 33(12): 1675-80.

Büchele G, Genuneit J, Weinmayr G, Björkstén B, Gehring U, von Mutius E, Priftanji A, Stein RT, Addo-Yobo EO, Priftis KN, Shah JR, Forastiere F, Svabe V, Crane J, Nystad W, García-Marcos L, Saraçlar Y, El-Sharif N, Strachan DP and the ISAAC Phase Two Study Group International Variations in Bronchial Responsiveness in Children: Findings From ISAAC Phase Two Pediatr Pulmonol 2010; 45(8): 796–806

Ellwood P, Asher MI, Björkstén B, Burr M, Pearce N, Robertson CF, and the ISAAC Phase One Study Group. Diet and asthma, allergic rhinoconjunctivitis and atopic eczema symptom prevalence: An ecological analysis of the International Study of Asthma and Allergies in Childhood (ISAAC) data. Eur Respir J 2001; 17(3): 436-443.

Ellwood P, Asher MI, Stewart AW and the ISAAC Phase III Study Group The impact of the method of consent on response rates in the ISAAC time trends study. Int J Tuberc Lung Dis. 2010 Aug;14(8):1059-65.

Ellwood P, Williams H, Aït-Khaled N, Björkstén B, Robertson C, and the ISAAC Phase III Study Group. Translation of questions: The International Study of Asthma and Allergies in Childhood (ISAAC) experience. Int J Tuberc Lung Dis.September 2009; 13(9): 1174-1182.

Flohr C, Weiland SK, Weinmayr G, Björkstén B, Bråbäck L, Brunekreef B, Büchele G, Clausen M, Cookson WOC, von Mutius E, Strachan DP, Williams HC, and the ISAAC Phase Two Study Group. The role of atopic sensitization in flexural eczema: Findings from the International Study of Asthma and Allergies in Childhood Phase Two. J Allergy Clin Immunol 2008; 121(1): 141-7.

Flohr C, Weinmayr G, Weiland SK (deceased), Addo-Yobo E, Annesi-Maesano I, Björkstén B, Bråbäck L, Büchele G, Chico M, Cooper P, Clausen M, El-Sharif N, Martínez Gimeno A, Mathur RS, von Mutius E, Morales Suárez-Varela MM, Pearce N, Svabe V, Wong GWK, Yu M, Zhong NS, Williams HC and the ISAAC Phase Two Study Group. How well do questionnaires perform compared with physical examination in detecting flexural eczema? Findings from the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Two. Br J Dermatol 2009; 161(4): 846-853. Epub 27 May.

Foliaki S, Kildegaard Nielsen S, Björkstén B, von Mutius E, Cheng S, Pearce N, and the ISAAC Phase One Study Group. Antibiotic sales and the prevalence of symptoms of asthma, rhinitis, and eczema: The International Study of Asthma and Allergies in Childhood (ISAAC). Int J Epidemiol 2004; 33(3): 558-63.

Foliaki S, Pearce N, Björkstén B, Mallol J, Montefort S, von Mutius E and the ISAAC Phase Three Study Group. Antibiotic use in infancy and risk of symptoms of asthma, rhinoconjunctivitis and eczema in 6 to 7 year old children: ISAAC Phase Three. J Allergy Clin Immunol 2009;124(5):982-9.

Gehring U, Strikwold M, Schram-Bijkerk D, Weinmayr G, Genuneit J, Nagel G, Wickens K, Siebers R, Crane J, Doekes G, Di Domenicantonio R, Nilsson L, Priftanji A, Sandin A, El-Sharif N, Strachan D, van Hage M, von Mutius E, Brunekreef B, and the ISAAC Phase Two Study Group. Asthma and allergic symptoms in relation to house dust endotoxin: Phase Two of the International Study on Asthma and Allergies in Childhood (ISAAC II). Clin Exp Allergy 2008; 38: 1911–1920.

Genuneit J, Cantelmo JL, Weinmayr G, Wong GWK, Cooper PJ, Riikjärv MA, Gotua M, Kabesch M, von Mutius E, Forastiere F, Crane J, Nystad W, El Sharif N, Batllés-Garrido J, García-Marcos L, García-Hernández G, Morales Suárez-Varela MM, Nilsson L, Bråbäck L, Saraçlar Y, Weiland SK, Cookson WOC, Strachan DP, Moffatt MF, ISAAC Phase Two Study Group. A multi-centre study of candidate genes for wheeze and allergy. The International Study of Asthma and Allergies in Childhood Phase Two. Clin Exp Allergy 2009 Dec; 39(12): 1875-1888

Lai CKW, Beasley R, Crane J, Foliaki S, Shah J, Weiland S, and the ISAAC Phase Three Study Group. Global variation in the prevalence and severity of asthma symptoms: Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 2009; 64: 476–483.Epub Feb 2009.

Mitchell EA, Stewart AW, on behalf of the ISAAC Phase One Study Group. The ecological relationship of tobacco smoking to the prevalence of symptoms of asthma and other atopic diseases in children: The International Study of Asthma and Allergies in Childhood (ISAAC). Eur J Epidemiol 2001; 17(7): 667-73.

Moffatt MF, Gut IG, Demenais F, Strachan DP, Bouzigon E, Heath S, von Mutius E, Farrall M, Lathrop M, Cookson WO for the GABRIEL Consortium. A large-scale, consortium-based genomewide association study of asthma N Engl J Med 2010; 363(13): 1211-21

Nagel G, Büchele G, Weinmayr G, Björkstén B, Chen Y-Z, Wang H, Nystad W, Saraçlar Y, Bråbäck L, Batllés-Garrido J, García-Hernández G, Weiland SK, and the ISAAC Phase Two Study Group. Effect of Breastfeeding on Asthma, Lung function, and Bronchial Hyperreactivity in ISAAC-Phase-Two. Eur Respir J.2009; 33: 993–1002; Epub 2009 Jan22.

Nagel G, Weinmayr G, Kleiner A, García-Marcos, Strachan DP, the ISAAC Phase Two Study Group. Effect of diet on asthma and allergic sensitisation in the International Study on Allergies and Asthma in Childhood (ISAAC) Phase Two. Thorax 2010; 65(6): 516-522 doi:10.1136/thx.2009.128256

Odhiambo J, Williams H, Clayton T, Robertson C, Asher MI, and the ISAAC Phase Three Study group. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three J Allergy Clin Immunol. Dec 2009;124(6):1251-8.

Pearce N, Aït-Khaled N, Beasley R, Mallol J, Keil U, Mitchell E, Robertson C, and the ISAAC Phase Three Study Group. Worldwide trends in the prevalence of asthma symptoms: Phase III of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 2007; 62(9): 758-66.

Pearce N, Sunyer J, Cheng S, Chinn S, Björkstén B, Burr M, Keil U, Anderson HR, Burney P, on behalf of the ISAAC Steering Committee and the European Community Respiratory Health Survey. Comparison of asthma prevalence in the ISAAC and the ECRHS. Eur Respir J 2000; 16(3): 420-6.

Pearce N, Weiland S, Keil U, Langridge P, Anderson HR, Strachan D, Bauman A, Young L, Gluyas P, Ruffin D, Crane J, Beasley R. Self-reported prevalence of asthma symptoms in children in Australia, England, Germany and New Zealand: an international comparison using the ISAAC protocol. Eur Respir J 1993; 6: 1455-61.

Shirtcliffe P, Weatherall M, Beasley R, on behalf of the ISAAC Phase One Study Group. An inverse correlation between estimated tuberculosis notification rates and asthma symptoms. Respirology 2002; 7(2): 153-5.

Stewart AW, Asher MI, Clayton TO, Crane J, D'Souza W, Ellwood PE, Ford RPK, Mitchell EA, Pattemore PK, Pearce N. The effect of season-of-response to ISAAC questions about asthma, rhinitis and eczema in children. Int J Epidemiol 1997; 26: 126-36.

Stewart AW, Mitchell EA, Pearce N, Strachan DP, Weiland SK, on behalf of the ISAAC Steering Committee. The relationship of per capita gross national product to the prevalence of symptoms of asthma and other atopic diseases in children (ISAAC). Int J Epidemiol 2001; 30: 173-9.

Strachan D, Sibbald B, Weiland S, Aït-Khaled N, Anabwani G, Anderson HR, Asher MI, Beasley R, Björkstén B, Burr M, Clayton T, Crane J, Ellwood P, Keil U, Lai C, Mallol J, Martinez F, Mitchell E, Montefort S, Pearce N, Robertson C, Shah J, Stewart A, von Mutius E, Williams H. Worldwide Variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol 1997; 8(4): 161-76.

The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 1998; 351(9111): 1225-32.

The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variations in the prevalence of asthma symptoms: the International Study of Asthma and Allergies in Childhood (ISAAC). Eur Respir J 1998; 12(2): 315-335.

von Mutius E, Pearce N, Beasley R, Cheng S, von Ehrenstein O, Björkstén B, Weiland S, on behalf of the ISAAC Steering Committee. International patterns of tuberculosis and the prevalence of symptoms of asthma, rhinitis and eczema. Thorax 2000; 55(6): 449-453.

Weiland SK, Hüsing A, Strachan D, Rzehak P, Pearce N, and the ISAAC Phase One Study Group. Climate and the prevalence of symptoms of asthma, allergic rhinitis and atopic eczema in children. Occup Environ Med 2004; 61(7): 609-15.

Weiland SK, von Mutius E, Hüsing A, Asher MI, on behalf of the ISAAC Steering Committee. Intake of trans fatty acids and prevalence of childhood asthma and allergies in Europe. Lancet 1999; 353(9169): 2040-1.

Weinmayr G, Forastiere F, Weiland SK, Rzehak P, Abramidze T, Annesi-Maesano I, Björkstén B, Brunekreef B, Büchele G, Cookson WO, von Mutius E, Pistelli R, Strachan DP, and the ISAAC Phase Two Study Group. International variation in prevalence of rhinitis and its relation with sensitization to perennial and seasonal allergens. Eur Respir J 2008; 32: 1250–1261.

Weinmayr G, Genuneit J, Nagel G, Björkstén B, van Hage M, Priftanji A, Cooper P, Rijkjärv M-A, von Mutius E, Tsanakas J, Forastiere F, Doekes G, Garrido JB, Morales Suárez-Varela MM, Bråbäck L, Strachan DP, the ISAAC Phase Two Study Group. International variations in associations of allergic markers and diseases in children: ISAAC Phase Two. Allergy 2010; 65(6): 766–775. epub 21 Dec 2009. DOI:10.1111/j.1398-9995.2009.02283.x

Weinmayr G, Weiland SK, Björkstén B, Brunekreef B, Büchele G, Cookson WO, García-Marcos L, Gotua M, Gratziou C, van Hage M, von Mutius E, Riikjärv MA, Rzehak P, Stein RT, Strachan DP, Tsanakas J, Wickens K, Wong GW, and the ISAAC Phase Two Study Group. Atopic sensitization and the international variation of asthma symptom prevalence in children. Am J Respir Crit Care Med 2007; 176(6): 565-74.

Williams H, Robertson C, Stewart A, Aït-Khaled N, Anabwani G, Anderson HR, Asher MI, Beasley R, Björkstén B, Burr M, Clayton T, Crane J, Ellwood P, Keil U, Lai C, Mallol J, Martinez F, Mitchell E, Montefort S, Pearce N, Shah J, Sibbald B, Strachan D, von Mutius E, Weiland S. Worldwide variations in the prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhood. J Allergy Clin Immunol 1999; 103(1 Pt 1): 125-38.

Williams H, Stewart A, von Mutius E, Cookson B, Anderson HR, and the ISAAC Phase One and Three Study groups. Is eczema really on the increase worldwide? J Allergy Clin Immunol 2008; 121(4): 947-54.